Dried blood spots via remote testing as a possible future application in the doping control process
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Stefan Trinks und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Anti Doping Agency Germany, Bonn, Germany. Hauptthemen laut MEDLINE: Doping in Sports, Dried Blood Spot Testing, Substance Abuse Detection. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Federal Ministry of the Interior and Community of the Federal Republic of Germany, Berlin, Germany.
Abstract (Originalsprache)
The use of DBS as biological matrix in combination with a novel technical remote testing app specifically developed for the doping control process shows that testing is becoming easier and variable through DBS. Supplemented by the remote testing solution, the system could significantly increase in the unpredictability of test dates and sample quantity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Anti Doping Agency Germany, Bonn, Germany.
- Sportradar Group AG, St. Gallen, Switzerland.
Förderung
- Federal Ministry of the Interior and Community of the Federal Republic of Germany, Berlin, Germany
Zitieren
APA
Trinks, S., Braun, K., Gotzmann, A., Bunthoff, E., & Mueser, D. (2024). Dried blood spots via remote testing as a possible future application in the doping control process. Drug Testing and Analysis. https://doi.org/10.1002/dta.3679
Vancouver
Trinks S, Braun K, Gotzmann A, Bunthoff E, Mueser D. Dried blood spots via remote testing as a possible future application in the doping control process. Drug Testing and Analysis. 2024. doi:10.1002/dta.3679
BibTeX
@article{Trinks2024,
author = {Trinks, Stefan and Braun, Kristina and Gotzmann, Andrea and Bunthoff, Eva and Mueser, Dominic},
title = {Dried blood spots via remote testing as a possible future application in the doping control process},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3679}
}
EUVIMED